Bacteriophage infection and killing of intracellular .

mBio

Department of Microbiology and Immunology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Published: January 2024

As we rapidly approach a post-antibiotic era, bacteriophage (phage) therapy may offer a solution for treating drug-resistant bacteria. is an emerging, multidrug-resistant pathogen that causes disease in people with cystic fibrosis, chronic obstructive pulmonary disease, and other underlying lung diseases. can survive inside host cells, a niche that can limit access to antibiotics. As current treatment options for infections often fail, there is an urgent need for alternative therapies. Phage therapy is being used to treat infections as an option of last resort. However, little is known about the ability of phages to kill bacteria in the host environment and specifically in an intracellular environment. Here, we demonstrate the ability of phages to enter mammalian cells and to infect and kill intracellular . These findings support the use of phages to treat intracellular bacterial pathogens.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10790704PMC
http://dx.doi.org/10.1128/mbio.02924-23DOI Listing

Publication Analysis

Top Keywords

phage therapy
8
ability phages
8
bacteriophage infection
4
infection killing
4
intracellular
4
killing intracellular
4
intracellular rapidly
4
rapidly approach
4
approach post-antibiotic
4
post-antibiotic era
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!